Top

International Journal of Diabetes in Developing Countries

Published in:

02-08-2022 | Magnetic Resonance Imaging | Review Article

A systematic review on foot muscle atrophy in patients with diabetes mellitus

Authors: Neerja Thukral, Jaspreet Kaur, Manoj Malik

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2023

Abstract

Introduction

Skeletal muscles respond heterogenically under various stresses and conditions like diabetes mellitus and cancer. Various imaging techniques like radiographs, ultrasonography, and MRI have been used to find out the muscle mass and cross-sectional area of foot muscles.

Objective

To summarize the findings of various imaging techniques to draw inference of presence of foot muscle atrophy in diabetic patients.

Methodology

Articles from databases-PubMed, Science Direct, Taylor & Francis, and Springer Link were retrieved.

Results

The imaging techniques confirm the presence of atrophy of foot muscles.

Conclusion

Based on the findings of study, it can be concluded that foot muscle atrophy is present in diabetics, with intrinsic muscles affected first in terms of decreased cross-sectional area, reduced plantar tissue and skin thickness, and a decrease in total foot muscle volume.

Sun Z, Liu L, Liu N, Liu Y. Muscular response and adaptation to diabetes mellitus. Front Biosci. 2008;13:4765–94. Published 2008 May 1. https://doi.org/10.2741/3038.CrossRefPubMed

Liu Y, Lormes W, Wang L, Reissnecker S, Steinacker JM. Different skeletal muscle HSP70 responses to high-intensity strength training and low-intensity endurance training. Eur J Appl Physiol. 2004;91(2-3):330–5. https://doi.org/10.1007/s00421-003-0976-2.CrossRefPubMed

Geriant Fuller, Mark Manford. Chapter 2- history and examination. Neurology 3^rd edition: An illustrated colout text.

Perry BD, Caldow MK, Brennan-Speranza TC, Sbaraglia M, Jerums G, Garnham A, Wong C, Levinger P, Asrar Ul Haq M, Hare DL, Price SR, Levinger I. Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immun Rev. 2016;22:94–109.

Frier BC, Noble EG, Locke M. Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-kappaB activation and expression. Cell Stress Chaperones. 2008;13(3):287–96. https://doi.org/10.1007/s12192-008-0062-0.CrossRefPubMedPubMedCentral

Kamei Y, Miura S, Suzuki M, et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem. 2004;279(39):41114–23. https://doi.org/10.1074/jbc.M400674200.CrossRefPubMed

Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles--a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI) [published correction appears in Diabetologia. 2009 Jul;52(7):1454]. Diabetologia. 2009;52(6):1182–91. https://doi.org/10.1007/s00125-009-1320-0.CrossRefPubMed

Neville RF, Kayssi A, Buescher T, Stempel MS. The diabetic foot. Curr Probl Surg. 2016;53(9):408–37. https://doi.org/10.1067/j.cpsurg.2016.07.003.CrossRefPubMed

Bandyk DF. The diabetic foot: Pathophysiology, evaluation, and treatment. Semin Vasc Surg. 2018;31(2-4):43–8. https://doi.org/10.1053/j.semvascsurg.2019.02.001.CrossRefPubMed

10.

Kumar CG, Rajagopal KV, Hande HM, Maiya AG, Mayya SS. Intrinsic foot muscle and plantar tissue changes in type 2 diabetes mellitus. J Diabetes. 2015;7(6):850–7. https://doi.org/10.1111/1753-0407.12254.CrossRefPubMed

11.

Cheuy VA, Hastings MK, Commean PK, Mueller MJ. Muscle and Joint Factors Associated With Forefoot Deformity in the Diabetic Neuropathic Foot. Foot Ankle Int. 2016;37(5):514–21. https://doi.org/10.1177/1071100715621544.CrossRefPubMed

12.

Cheuy VA, Hastings MK, Commean PK, Ward SR, Mueller MJ. Intrinsic foot muscle deterioration is associated with metatarsophalangeal joint angle in people with diabetes and neuropathy. Clin Biomech (Bristol, Avon). 2013;28(9-10):1055–60. https://doi.org/10.1016/j.clinbiomech.2013.10.006.CrossRefPubMedPubMedCentral

13.

Andersen H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care. 2004;27(10):2382–5. https://doi.org/10.2337/diacare.27.10.2382.CrossRefPubMed

14.

Bus SA, Yang QX, Wang JH, Smith MB, Wunderlich R, Cavanagh PR. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care. 2002;25(8):1444–50. https://doi.org/10.2337/diacare.25.8.1444.CrossRefPubMed

15.

Smith KE, Commean PK, Mueller MJ, Robertson DD, Pilgram T, Johnson J. Assessment of the diabetic foot using spiral computed tomography imaging and plantar pressure measurements: a technical report. J Rehabil Res Dev. 2000;37(1):31–40.PubMed

16.

Sanverdi SE, Ergen BF, Oznur A. Current challenges in imaging of the diabetic foot. Diabet Foot Ankle. 2012;3. https://doi.org/10.3402/dfa.v3i0.18754.

17.

Sun JH, Cheng BK, Zheng YP, Huang YP, Leung JY, Cheing GL. Changes in the thickness and stiffness of plantar soft tissues in people with diabetic peripheral neuropathy. Arch Phys Med Rehabil. 2011;92(9):1484–9. https://doi.org/10.1016/j.apmr.2011.03.015.CrossRefPubMed

18.

Henderson AD, Johnson AW, Rasmussen LG, et al. Early-stage diabetic neuropathy reduces foot strength and intrinsic but not extrinsic foot muscle size. J Diabetes Res. 2020;2020:9536362. Published 2020 Mar 12. https://doi.org/10.1155/2020/9536362.CrossRefPubMedPubMedCentral

19.

Chao CY, Zheng YP, Cheing GL. Epidermal thickness and biomechanical properties of plantar tissues in diabetic foot. Ultrasound Med Biol. 2011;37(7):1029–38. https://doi.org/10.1016/j.ultrasmedbio.2011.04.004.CrossRefPubMed

20.

Severinsen K, Andersen H. Evaluation of atrophy of foot muscles in diabetic neuropathy -- a comparative study of nerve conduction studies and ultrasonography. Clin Neurophysiol. 2007;118(10):2172–5. https://doi.org/10.1016/j.clinph.2007.06.019.CrossRefPubMed

21.

Greenman RL, Khaodhiar L, Lima C, Dinh T, Giurini JM, Veves A. Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care. 2005;28(6):1425–30. https://doi.org/10.2337/diacare.28.6.1425.CrossRefPubMed

22.

Bus SA, Maas M, Michels RP, Levi M. Role of intrinsic muscle atrophy in the etiology of claw toe deformity in diabetic neuropathy may not be as straightforward as widely believed. Diabetes Care. 2009;32(6):1063–7. https://doi.org/10.2337/dc08-2174.CrossRefPubMedPubMedCentral

23.

Severinsen K, Obel A, Jakobsen J, Andersen H. Atrophy of foot muscles in diabetic patients can be detected with ultrasonography. Diabetes Care. 2007;30(12):3053–7. https://doi.org/10.2337/dc07-0108.CrossRefPubMed

24.

Wang X, Chen L, Liu W, Su B, Zhang Y. Early detection of atrophy of foot muscles in Chinese patients of type 2 diabetes mellitus by high-frequency ultrasonography. J Diabetes Res. 2014;2014:927069. https://doi.org/10.1155/2014/927069.CrossRefPubMedPubMedCentral

25.

Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. Published 2021 Mar 29. https://doi.org/10.1136/bmj.n160.CrossRefPubMedPubMedCentral

26.

McGraw H. The CARS Checklist (Credibility, Accuracy, Reasonableness, Support). 2003. http://novella.mhhe.com/sites/0079876543/student_view0/research_center999/research_papers30/conducting_web-based_research.html

27.

Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7. Published 2020 Feb 29. https://doi.org/10.1186/s40779-020-00238-8.CrossRefPubMedPubMedCentral

28.

Mayans D, Cartwright MS, Walker FO. Neuromuscular ultrasonography: quantifying muscle and nerve measurements. Phys Med Rehabil Clin N Am. 2012;23(1):133–xii. https://doi.org/10.1016/j.pmr.2011.11.009.CrossRefPubMed

29.

Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assessment of human skeletal muscle size. Eur J Appl Physiol. 2004;91(1):116–8. https://doi.org/10.1007/s00421-003-0961-9.CrossRefPubMed

30.

Esformes JI, Narici MV, Maganaris CN. Measurement of human muscle volume using ultrasonography. Eur J Appl Physiol. 2002;87(1):90–2. https://doi.org/10.1007/s00421-002-0592-6.CrossRefPubMed

31.

Theodorou DJ, Theodorou SJ, Kakitsubata Y. Skeletal muscle disease: patterns of MRI appearances. Br J Radiol. 2012;85(1020):e1298–308. https://doi.org/10.1259/bjr/14063641.CrossRefPubMedPubMedCentral

32.

del Porto LA, Nicholson GA, Ketheswaren P. Correlation between muscle atrophy on MRI and manual strength testing in hereditary neuropathies. J Clin Neurosci. 2010;17(7):874–8. https://doi.org/10.1016/j.jocn.2009.11.006.CrossRefPubMed

Title: A systematic review on foot muscle atrophy in patients with diabetes mellitus
Authors: Neerja Thukral
Jaspreet Kaur
Manoj Malik
Publication date: 02-08-2022
Publisher: Springer India
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Diabetes
Published in: International Journal of Diabetes in Developing Countries / Issue 3/2023
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-022-01118-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Objective

Methodology

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2023

Nerve conduction study abnormalities in Indian children with type 1 diabetes

Serum glucose, a cost-effective alternate of plasma glucose in diagnosing and monitoring diabetes mellitus

Pattern of clinical/bacteriological profile and follow-up of symptomatic urinary tract infection in patients with diabetes: a cross-sectional study from North India

Emerging health care technologies in diabetes: is it the way forward?

National and regional prevalence rates of diabetes in Saudi Arabia: analysis of national survey data

Telemedicine with advanced communication technology in management of type 2 diabetes mellitus: a network meta-analysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials